Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
SEC Accession No. 0001012975-25-000438
Filing Date
2025-08-13
Accepted
2025-08-13 16:05:48
Documents
2
Period of Report
2025-06-30
Effectiveness Date
2025-08-13

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 13F-HR  
1 primary_doc.xml 13F-HR 2414
2 INFORMATION TABLE infotable.html INFORMATION TABLE  
2 INFORMATION TABLE infotable.xml INFORMATION TABLE 7059
  Complete submission text file 0001012975-25-000438.txt   10692
Mailing Address 501 2ND ST, SUITE 200 SAN FRANCISCO CA 94107
Business Address 501 2ND ST, SUITE 200 SAN FRANCISCO CA 94107 415-948-7474
Pivotal bioVenture Partners Investment Advisor LLC (Filer) CIK: 0001844645 (see all company filings)

EIN.: 814749159 | State of Incorp.: DE
Type: 13F-HR | Act: 34 | File No.: 028-20630 | Film No.: 251211520